News

Private-equity firm Warburg Pincus is near a deal to buy specialty-pharmacy company PantheRx Rare for over $7 billion, including debt, according to people familiar with the matter. PantheRx Rare is owned by an investor consortium that includes private-equity firm General Atlantic. A deal could come together soon, the people said, cautioning that nothing is finalized and the timing could still slip.

In late June 2026, Centene’s Illinois subsidiary Meridian Health Plan of Illinois secured a four‑year renewal to continue serving the HealthChoice Illinois Medicaid managed care program from 2027 to 2030, while Centene was also reclassified into several Russell growth benchmarks and removed from certain defensive and value‑defensive indexes. This combination of a large Medicaid contract renewal in a key state and index moves toward growth benchmarks highlights Centene’s evolving profile as...

The health care giant sent a torrent of cash to its owners, but the stock itself told a very different story about the last five years.

The healthcare giant looks expensive at a glance, but a patient investor is effectively buying its future earnings at a significant discount.

CNC is turning operational improvements into margin gains, with stronger cost controls and AI-driven tools supporting profitability. Can the momentum continue?

UnitedHealth plans to invest nearly $1.5B in AI for 2026, expanding automation, digital tools and software platforms to drive growth beyond traditional cost savings.

ARHOME represents a small portion of Centene’s overall membership and premiums. But the exit represents how insurers are rejigging their businesses in advance of Medicaid work requirements, one analyst said.

Insurers want to do the same next year. “It is a stunning jump” when you add both years together, said Cynthia Cox, senior vice president at KFF, a health-research nonprofit. At the request of The Wall Street Journal, KFF analyzed the rate requests for the largest ACA plans by enrollment in 15 states where insurers’ 2027 filings have already become public, as well as the District of Columbia.

Looking back on health insurance providers stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Centene (NYSE:CNC) and its peers.

CNC expands AI-driven fraud prevention and payment integrity to improve Medicaid margins, boost cost controls and support long-term earnings growth.

While Wall Street fixated on a gloomy forecast, the company was making a painful but telling choice that hinted at the turnaround to come.

Centene is set to announce its second-quarter earnings next month, and Wall Street expects a high triple-digit surge in its profits.

CNC's integrated healthcare model, AI-driven operations and improving Medicaid margins are strengthening earnings as the company raises 2026 EPS guidance.

Baird said the outcomes from the final 2025 healthcare exchange risk adjustment transfers support Centene’s prior Q4 commentary and align directionally with Oscar’s comments at a June investor conference.

Centene Corporation (NYSE:CNC) is one of billionaire Cliff Asness’ top 10 healthcare stock picks. On June 23, RBC Capital analyst Ben Hendrix initiated coverage of Centene Corporation (NYSE:CNC) with a Sector Perform rating and a price target of $70. Hendrix acknowledged that Centene entered 2026 showing clear early signs of a recovery, which is a […]

Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.

CLS, CBOE, and CNC it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 29, 2026.

Centene (NYSE:CNC) has appointed Lauren M. Tyler to its Board of Directors. Tyler brings leadership experience from major financial institutions, including roles in investment banking, private equity, corporate audit, investor relations, and human capital strategy. Her background includes senior positions at JPMorgan Chase & Co. and board service across several organizations. For investors tracking Centene, the board appointment comes at a time when the stock trades around $65.73, with the...

CBOE, CNC and CRDO made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 25th, 2026.

Incoming board member Lauren Tyler has more than 30 years of leadership experience in the finance world, which could help Centene navigate the challenging operating environment facing insurers.

Centene (CNC) is seeing clear early signs of recovery this year after a disruptive 2025, RBC Capital

Pre-Market Stock Futures: Futures are trading lower after a mixed start to trading on Monday, following the holiday-shortened week due to the Juneteenth Federal holiday. We may start to see some end-of-the-quarter reallocations and selling for Hedge funds, ETFs, and Mutual Funds this week, and today looks like a starting point. With most corporate buybacks ... Here Are Tuesday’s Best Wall Street Analyst Research Calls: Centene, Darden Restaurants, Flutter Entertainment, GE Healthcare, IBM, Nike,

Medical stocks Centene, DaVita and BrightSpring are gaining attention as healthcare tailwinds and market optimism support growth.

CBOE, CNC and CRDO made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 23rd, 2026.

A Healthcare Company Delivering Eye-catching Earnings Surprises and a Renewable Energy Company That's a Big Winner in AI Datacenter Buildout.

Medical stocks like Centene, DaVita and BrightSpring could rally as SpaceX IPO-fueled market optimism lifts broader sector sentiment.

Centene (CNC) has drawn fresh attention after launching a voluntary buyout program for most employees, in response to a substantial drop in health plan membership tied to expiring federal pandemic subsidies and higher consumer costs. See our latest analysis for Centene. At a share price of $61.02, Centene has seen a 77.38% 90 day share price return and a 46.05% year to date share price return, while the 5 year total shareholder return has declined 17.43%. This suggests strong recent momentum...

In recent days, Centene offered voluntary buyouts to most of its roughly 61,000 employees after experiencing significant membership declines in its Affordable Care Act and Medicaid health plans. This workforce move, coupled with broader cost-cutting efforts, underscores how shifts in government-backed coverage can quickly reshape a major insurer’s operating footprint and priorities. We’ll now examine how offering broad voluntary employee buyouts to cut costs may influence Centene’s...

Centene (NYSE:CNC) has launched a wide-scale voluntary separation program, offering buyouts to most of its roughly 61,000 employees. The move comes as the company faces sharp health plan membership declines, particularly in its Medicaid and Affordable Care Act businesses. Centene has indicated that layoffs could follow if voluntary exits do not meet internal targets. The program is unfolding against a backdrop of major workforce restructuring and evolving regulatory and eligibility...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.